Clinical Trial

Dietary Prevention of Type 2 Diabetes

Study Description

The TCF7L2 Gene: Dietary Prevention of T2DM

Nutrients and chemicals in food are able to regulate expression of genetic elements. Gene-nutrient interaction in response specific diets can increase an individual's risk, shifting the individual from health toward the development of chronic disease. The Transcription Factor 7 Like 2 (TCF7L2) gene may either put individuals at risk for or protect from Type 2 diabetes mellitus in the presence of certain foods. The main purpose of this four-week study is to examine diet-induced gene-nutrient interaction, with a focus on glucose, insulin, inflammation (CRP) and the plasma metabolome in individuals who have either the CC or the TT form of the rs7903146 single nucleotide polymorphism (SNP) (C/T) within the TCF7L2 gene. The (2) one-week study diets, one Mediterranean diet (MedDiet) based and the other low-fat based will be separated by a (1) week return to a regular habitual diet.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Mediterranean Diet

Participants will receive meals traditionally consumed in Mediterranean countries

Low-fat diet

Participants will receive meals with a low content of total fat.

Additional Information

Official Study Title

The TCF7L2 Gene: Nutrigenomics and Dietary Prevention of Type 2 Diabetes

Clinical Trial ID

NCT03458494

ParticipAid ID

PdRpYa